UMIN-CTR Clinical Trial

Recruitment status Open public recruiting
Unique ID issued by UMIN UMIN000047012
Receipt No. R000053637
Scientific Title Analysis and prognostic significance of biological samples from patients with severe heart failure requiring ventricular assist device (VAD) and heart transplantation
Date of disclosure of the study information 2022/02/26
Last modified on 2022/08/28 (Ver. 2)

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information
Public title Analysis and prognostic significance of biological samples from patients with severe heart failure requiring ventricular assist device (VAD) and heart transplantation
Acronym Research on biological samples from patients with severe heart failure requiring VAD and heart transplantation
Scientific Title Analysis and prognostic significance of biological samples from patients with severe heart failure requiring ventricular assist device (VAD) and heart transplantation
Scientific Title:Acronym Research on biological samples from patients with severe heart failure requiring VAD and heart transplantation
Region
Japan

Condition
Condition Heart failure
Classification by specialty
Cardiology
Classification by malignancy Others
Genomic information YES

Objectives
Narrative objectives1 We will accumulate clinical information and biological samples from patients with VAD and severe heart failure requiring heart transplantation, and conduct pathological analysis as well as comprehensive analysis at each level of genome, RNA, protein, epigenome, and mitochondria (multi-layered omics analysis) to identify key factors in the pathogenesis and pathogenesis of myocardial damage and complications. In addition, we aim to identify key factors in the pathogenesis of myocardial disorders and complications. In addition, we will examine the relationship with prognosis by examining endpoints on a continuous and long-term basis.
Basic objectives2 Others
Basic objectives -Others N/A
Trial characteristics_1
Trial characteristics_2
Developmental phase

Assessment
Primary outcomes Relationship between findings from various biological samples and incidence of all-cause mortality, cardiovascular death, and heart failure hospitalization
Key secondary outcomes Relationship between findings from various biological samples and infections (driveline infection, pocket infection, sepsis, mediastinal sinusitis, etc.), heart failure (pump dysfunction, right heart failure), device failure (pump, controller), device thrombosis, hemolysis, arrhythmia, multiple organ failure (liver, kidney, lung, etc.), cerebral neuropathy (stroke, cerebral hemorrhage), gastrointestinal bleeding, and aortic regurgitation.
The relationship between findings from various biological samples and acute complications (acute rejection, graft failure, infection, multi-organ failure, renal failure) and chronic complications (transplant coronary artery lesions, malignancy, lymphoma) after heart transplantation.
Relationship between findings from various biological samples and patient background, cardiac MRI, cardiac PET, and blood test data.

Base
Study type Observational

Study design
Basic design
Randomization
Randomization unit
Blinding
Control
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment

Intervention
No. of arms
Purpose of intervention
Type of intervention
Interventions/Control_1
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10

Eligibility
Age-lower limit
18 years-old <=
Age-upper limit

Not applicable
Gender Male and Female
Key inclusion criteria (1) Age 18 years or older at the time of obtaining consent
(2) Those who have freely and voluntarily consented to participate in this research for research subjects using specimens, and those who do not refuse to participate in the research for research subjects using only medical information.
Key exclusion criteria (1) Persons who are judged by the Principal Investigator to be inappropriate as research subjects.
Target sample size 70

Research contact person
Name of lead principal investigator
1st name Toshiyuki
Middle name
Last name Nagai
Organization Faculty of Medicine and Graduate School of Medicine, Hokkaido University
Division name Department of Cardiovascular Medicine
Zip code 060-8638
Address Kita-15, Nishi-7, Kita-ku, Sapporo, Japan
TEL 011-706-6973
Email tnagai@huhp.hokudai.ac.jp

Public contact
Name of contact person
1st name Sakae
Middle name
Last name Takenaka
Organization Faculty of Medicine and Graduate School of Medicine, Hokkaido University
Division name Department of Cardiovascular Medicine
Zip code 0608638
Address Kita-15, Nishi-7, Kita-ku, Sapporo, Japan
TEL 0117066973
Homepage URL
Email stakenaka1102@gmail.com

Sponsor
Institute Hokkaido University
Institute
Department

Funding Source
Organization Non profit foundation
Organization
Division
Category of Funding Organization Self funding
Nationality of Funding Organization

Other related organizations
Co-sponsor
Name of secondary funder(s)

IRB Contact (For public release)
Organization Ethical Review Board for Life Science and Medical Research, Hokkaido University Hospital
Address Kita-14, Nishi-5, Kita-ku, Sapporo, Japan
Tel 011-706-7636
Email crjimu@huhp.hokudai.ac.jp

Secondary IDs
Secondary IDs NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW

Institutions
Institutions 北海道大学病院(北海道)

Other administrative information
Date of disclosure of the study information
2022 Year 02 Month 26 Day

Related information
URL releasing protocol
Publication of results Unpublished

Result
URL related to results and publications
Number of participants that the trial has enrolled
Results
Results date posted
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description

Progress
Recruitment status Open public recruiting
Date of protocol fixation
2022 Year 02 Month 14 Day
Date of IRB
2022 Year 02 Month 14 Day
Anticipated trial start date
2022 Year 02 Month 28 Day
Last follow-up date
2031 Year 12 Month 31 Day
Date of closure to data entry
Date trial data considered complete
Date analysis concluded

Other
Other related information none

Management information
Registered date
2022 Year 02 Month 26 Day
Last modified on
2022 Year 08 Month 28 Day


Link to view the page
URL(English) https://center6.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000053637